What Researchers Did
Doctors in Chile reported the case of a Crohn's disease patient with an ischaemic ulcer at a surgical reconnection site in the intestine who received HBOT after standard biological therapies failed to achieve remission.
What They Found
The patient showed clinical and endoscopic improvement after receiving HBOT as an add-on treatment. The ischaemic ulcer at the ileo-rectal anastomosis responded to the therapy, and the patient's condition improved where other treatments had not succeeded.
Canadian Relevance
No direct Canadian connection identified. Canada has among the world's highest rates of inflammatory bowel disease, making this research particularly relevant to Canadian patients.
Study Limitations
This is a single case report from Chile, so it cannot establish that HBOT reliably works for Crohn's disease patients in general.